Process for the preparation of 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds

EP4758148A1Pending Publication Date: 2026-06-17F HOFFMANN LA ROCHE & CO AG

Patent Information

Authority / Receiving Office
EP · EP
Patent Type
Applications
Current Assignee / Owner
F HOFFMANN LA ROCHE & CO AG
Filing Date
2024-08-06
Publication Date
2026-06-17

AI Technical Summary

Technical Problem

Existing processes for manufacturing 3-substituted 5-amino-6/7-thiazolo[4,5-rf]pyrimidine-2,7-dione compounds suffer from low purity and yield due to harsh reaction conditions, low selectivity, and the need for additional purification steps.

Method used

A process involving specific reaction steps such as reacting a compound of formula (VIII) with a Grignard reagent in the presence of a copper catalyst, followed by acylating agents and silylating agents, to form compound (XIII), which is then reacted with an acid and an aqueous base to achieve compound (la) with improved purity and yield.

Benefits of technology

The proposed process enhances the purity and yield of the compound (la), allowing for its isolation in the free form in high purity and simplifying the manufacturing process, making it more suitable for large-scale production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure EP2024072228_13022025_PF_FP_ABST
    Figure EP2024072228_13022025_PF_FP_ABST
Patent Text Reader

Abstract

The present invention relates to a novel process for the preparation of a compound of formula (Ia), or a pharmaceutically acceptable salt thereof, (formula (Ia)), wherein R1 is H or C1-6 alkyl, R2 is H or hydroxy.
Need to check novelty before this filing date? Find Prior Art